Stock Price
473.42
Daily Change
-7.10 -1.48%
Monthly
0.78%
Yearly
31.11%
Q1 Forecast
458.74

United Therapeutics reported $7.16 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 7.07 6.19 Feb/25 2026
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29 2025
FY2025Q2 Jun/2025 6.41 7.35 5.85 Jul/30 2025
FY2025Q1 Mar/2025 6.63 6.53 6.17 Apr/30 2025
FY2024Q4 Dec/2024 6.19 6.68 4.36 Feb/26 2025




Eps Change Date
Amarin USD 0.08 0.11 Sep/2025
Ardelyx USD 0 0.08 Sep/2025
Baxter International USD 0.44 0.25 Dec/2025
Bayer EUR 0.57 0.66 Sep/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Lexicon Pharmaceuticals USD -0.17 0.02 Jun/2024
Moderna USD -2.11 1.6 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025